OKI-219

OKI-219 · OnKure, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for OKI-219, covering 2025-09-09 to 2025-09-09. Get the full timeline:

Most recent: Clinical Trial Update: First-in-Human Study of OKI-219 in Advanced Solid Tumors and Advanced Breast Cancer [Phase 1]